Our site may be slower due to heavy traffic from automated "bots" and AI crawlers. We're working to fix this.

Boris Minev

Title(s)Associate Clinical Professor (Voluntary), Radiation Medicine and Applied Science
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Biomimetic and personalized nanovaccines in cancer immunotherapy: Design innovations, translational challenges, and future directions. J Adv Res. 2026 Feb 02. Xu S, Yang H, Minev B, Ma W. PMID: 41638631.
      View in: PubMed   Mentions:    Fields:    
    2. Reduction of solid tumors by senescent cell immunization. J Transl Med. 2025 Nov 28; 23(1):1365. Ichim TE, Lopes G, Reznik R, Bykoriz V, Fortunati CA, Pascual KA, Minev B, Ramos RA, Bajnath A, Lin E, Hu J, Marincola FM, Rath A, Reznik BN. PMID: 41316207; PMCID: PMC12661736.
      View in: PubMed   Mentions: 1     Fields:    
    3. Neoadjuvant clinical trials in adults with newly diagnosed high-grade glioma: A systematic review. Crit Rev Oncol Hematol. 2025 Feb; 206:104596. Juarez TM, Gill JM, Minev BR, Sharma A, Kesari S. PMID: 39675399.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    4. Development of Allogeneic Stem Cell-Based Platform for Delivery and Potentiation of Oncolytic Virotherapy. Cancers (Basel). 2022 Dec 13; 14(24). Nguyen DH, Herrmann T, Härtl B, Draganov D, Minev I, Neuharth F, Gomez A, Alamillo A, Schneider LE, Kleinholz D, Minev B, Santidrian AF. PMID: 36551636; PMCID: PMC9777144.
      View in: PubMed   Mentions: 3  
    5. Correction to: Delivery of oncolytic vaccinia virus by matched allogeneic stem cells overcomes critical innate and adaptive immune barriers. J Transl Med. 2021 Oct 04; 19(1):414. Draganov DD, Santidrian AF, Minev I, Nguyen D, Kilinc MO, Petrov I, Vyalkova A, Lander E, Berman M, Minev B, Szalay AA. PMID: 34607595; PMCID: PMC8489066.
      View in: PubMed   Mentions:    Fields:    
    6. Novel Survivin Peptides Screened With Computer Algorithm Induce Cytotoxic T Lymphocytes With Higher Cytotoxic Efficiency to Cancer Cells. Front Mol Biosci. 2020; 7:570003. Chen Q, Jia G, Zhao X, Bao Y, Zhang Y, Ozkan C, Minev B, Ma W. PMID: 33102521; PMCID: PMC7496070.
      View in: PubMed   Mentions: 5  
    7. Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients. J Transl Med. 2020 05 18; 18(1):203. Rogers CJ, Harman RJ, Bunnell BA, Schreiber MA, Xiang C, Wang FS, Santidrian AF, Minev BR. PMID: 32423449; PMCID: PMC7232924.
      View in: PubMed   Mentions: 67     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    8. Tumor growth inhibition by mSTEAP peptide nanovaccine inducing augmented CD8+ T cell immune responses. Drug Deliv Transl Res. 2019 12; 9(6):1095-1105. Chen Q, Bao Y, Burner D, Kaushal S, Zhang Y, Mendoza T, Bouvet M, Ozkan C, Minev B, Ma W. PMID: 31228097.
      View in: PubMed   Mentions: 14     Fields:    Translation:AnimalsCells
    9. First-in-human study of TK-positive oncolytic vaccinia virus delivered by adipose stromal vascular fraction cells. J Transl Med. 2019 08 19; 17(1):271. Minev BR, Lander E, Feller JF, Berman M, Greenwood BM, Minev I, Santidrian AF, Nguyen D, Draganov D, Killinc MO, Vyalkova A, Kesari S, McClay E, Carabulea G, Marincola FM, Butterfield LH, Szalay AA. PMID: 31426803; PMCID: PMC6699108.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCellsCTClinical Trials
    10. Delivery of oncolytic vaccinia virus by matched allogeneic stem cells overcomes critical innate and adaptive immune barriers. J Transl Med. 2019 03 27; 17(1):100. Draganov DD, Santidrian AF, Minev I, Nguyen D, Kilinc MO, Petrov I, Vyalkova A, Lander E, Berman M, Minev B, Szalay AA. PMID: 30917829; PMCID: PMC6437877.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansAnimalsCells
    11. Epithelial membrane protein 2: a novel biomarker for circulating tumor cell recovery in breast cancer. Clin Transl Oncol. 2019 Apr; 21(4):433-442. Chen Q, Yao L, Burner D, Minev B, Lu L, Wang M, Ma W. PMID: 30218306.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    12. The ratio of ADSCs to HSC-progenitors in adipose tissue derived SVF may provide the key to predict the outcome of stem-cell therapy. Clin Transl Med. 2018 Feb 07; 7(1):5. Kilinc MO, Santidrian A, Minev I, Toth R, Draganov D, Nguyen D, Lander E, Berman M, Minev B, Szalay AA. PMID: 29417261; PMCID: PMC5803165.
      View in: PubMed   Mentions: 21     Fields:    
    13. Artificial human antigen-presenting cells are superior to dendritic cells at inducing cytotoxic T-cell responses. Immunology. 2017 11; 152(3):462-471. Li H, Shao S, Cai J, Burner D, Lu L, Chen Q, Minev B, Ma W. PMID: 28664991; PMCID: PMC5629434.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    14. IFNγ enhances cytotoxic efficiency of the cytotoxic T lymphocytes against human glioma cells. Int Immunopharmacol. 2017 Jun; 47:159-165. Shao S, Risch E, Burner D, Lu L, Minev B, Ma W. PMID: 28410529.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    15. Humanized Mice with Subcutaneous Human Solid Tumors for Immune Response Analysis of Vaccinia Virus-Mediated Oncolysis. Mol Ther Oncolytics. 2017 Jun 16; 5:41-61. Tsoneva D, Minev B, Frentzen A, Zhang Q, Wege AK, Szalay AA. PMID: 28480327; PMCID: PMC5415323.
      View in: PubMed   Mentions: 19  
    16. Colonization of xenograft tumors by oncolytic vaccinia virus (VACV) results in enhanced tumor killing due to the involvement of myeloid cells. J Transl Med. 2016 12 20; 14(1):340. Kilinc MO, Ehrig K, Pessian M, Minev BR, Szalay AA. PMID: 27993141; PMCID: PMC5168712.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    17. Expression of anti-VEGF antibody together with anti-EGFR or anti-FAP enhances tumor regression as a result of vaccinia virotherapy. Mol Ther Oncolytics. 2015; 2:15003. Huang T, Wang H, Chen NG, Frentzen A, Minev B, Szalay AA. PMID: 27119102; PMCID: PMC4782963.
      View in: PubMed   Mentions: 20  
    18. Overcoming tumor immune evasion with an unique arbovirus. J Transl Med. 2015 Jan 16; 13:3. Lyday B, Chen T, Kesari S, Minev B. PMID: 25592450; PMCID: PMC4307212.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    19. TLR4-dependent activation of dendritic cells by an HMGB1-derived peptide adjuvant. J Transl Med. 2014 Aug 14; 12:211. Saenz R, Futalan D, Leutenez L, Eekhout F, Fecteau JF, Sundelius S, Sundqvist S, Larsson M, Hayashi T, Minev B, Carson D, Esener S, Messmer B, Messmer D. PMID: 25123824; PMCID: PMC4261565.
      View in: PubMed   Mentions: 57     Fields:    Translation:HumansAnimalsCells
    20. Intravenous ascorbic acid as an adjuvant to interleukin-2 immunotherapy. J Transl Med. 2014 May 13; 12:127. Wagner SC, Markosian B, Ajili N, Dolan BR, Kim AJ, Alexandrescu DT, Dasanu CA, Minev B, Koropatnick J, Marincola FM, Riordan NH. PMID: 24884532; PMCID: PMC4028098.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    21. Optical detection and virotherapy of live metastatic tumor cells in body fluids with vaccinia strains. PLoS One. 2013; 8(9):e71105. Wang H, Chen NG, Minev BR, Zimmermann M, Aguilar RJ, Zhang Q, Sturm JB, Fend F, Yu YA, Cappello J, Lauer UM, Szalay AA. PMID: 24019862; PMCID: PMC3760980.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    22. Biotherapeutic approaches to target cancer stem cells. J Stem Cells. 2013; 8(3-4):135-49. Duggal R, Minev B, Geissinger U, Wang H, Chen NG, Koka PS, Szalay AA. PMID: 24699023.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    23. Functional role of solid tumor stem cells in disease etiology and susceptibility to therapeutic interventions. J Stem Cells. 2013; 8(3-4):189-231. Ramdass B, Duggal R, Minev B, Chowdhary A, Koka P. PMID: 24699025.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    24. Oncolytic vaccinia virus GLV-1h68 strain shows enhanced replication in human breast cancer stem-like cells in comparison to breast cancer cells. J Transl Med. 2012 Aug 17; 10:167. Wang H, Chen NG, Minev BR, Szalay AA. PMID: 22901246; PMCID: PMC3478222.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansAnimalsCells
    25. Characterization of iNOS(+) Neutrophil-like ring cell in tumor-bearing mice. J Transl Med. 2012 Jul 30; 10:152. Virtuoso LP, Harden JL, Sotomayor P, Sigurdson WJ, Yoshimura F, Egilmez NK, Minev B, Kilinc MO. PMID: 22846631; PMCID: PMC3478162.
      View in: PubMed   Mentions: 7     Fields:    Translation:Animals
    26. PLGA nanoparticle-mediated delivery of tumor antigenic peptides elicits effective immune responses. Int J Nanomedicine. 2012; 7:1475-87. Ma W, Chen M, Kaushal S, McElroy M, Zhang Y, Ozkan C, Bouvet M, Kruse C, Grotjahn D, Ichim T, Minev B. PMID: 22619507; PMCID: PMC3356185.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansAnimalsCells
    27. Autologous stromal vascular fraction therapy for rheumatoid arthritis: rationale and clinical safety. Int Arch Med. 2012 Feb 08; 5:5. Rodriguez JP, Murphy MP, Hong S, Madrigal M, March KL, Minev B, Harman RJ, Chen CS, Timmons RB, Marleau AM, Riordan NH. PMID: 22313603; PMCID: PMC3296619.
      View in: PubMed   Mentions: 14  
    28. Enhanced presentation of MHC class Ia, Ib and class II-restricted peptides encapsulated in biodegradable nanoparticles: a promising strategy for tumor immunotherapy. J Transl Med. 2011 Mar 31; 9:34. Ma W, Smith T, Bogin V, Zhang Y, Ozkan C, Ozkan M, Hayden M, Schroter S, Carrier E, Messmer D, Kumar V, Minev B. PMID: 21450109; PMCID: PMC3078865.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    29. Intravenous ascorbic acid to prevent and treat cancer-associated sepsis? J Transl Med. 2011 Mar 04; 9:25. Ichim TE, Minev B, Braciak T, Luna B, Hunninghake R, Mikirova NA, Jackson JA, Gonzalez MJ, Miranda-Massari JR, Alexandrescu DT, Dasanu CA, Bogin V, Ancans J, Stevens RB, Markosian B, Koropatnick J, Chen CS, Riordan NH. PMID: 21375761; PMCID: PMC3061919.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    30. Feasibility of combination allogeneic stem cell therapy for spinal cord injury: a case report. Int Arch Med. 2010 Nov 11; 3:30. Ichim TE, Solano F, Lara F, Paris E, Ugalde F, Rodriguez JP, Minev B, Bogin V, Ramos F, Woods EJ, Murphy MP, Patel AN, Harman RJ, Riordan NH. PMID: 21070647; PMCID: PMC2989319.
      View in: PubMed   Mentions: 34  
    31. Safety evaluation of allogeneic umbilical cord blood mononuclear cell therapy for degenerative conditions. J Transl Med. 2010 Aug 03; 8:75. Yang WZ, Zhang Y, Wu F, Min WP, Minev B, Zhang M, Luo XL, Ramos F, Ichim TE, Riordan NH, Hu X. PMID: 20682053; PMCID: PMC2922090.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCTClinical Trials
    32. Combination stem cell therapy for heart failure. Int Arch Med. 2010 Apr 14; 3(1):5. Ichim TE, Solano F, Lara F, Rodriguez JP, Cristea O, Minev B, Ramos F, Woods EJ, Murphy MP, Alexandrescu DT, Patel AN, Riordan NH. PMID: 20398245; PMCID: PMC3003238.
      View in: PubMed   Mentions: 21  
    33. Nutraceutical augmentation of circulating endothelial progenitor cells and hematopoietic stem cells in human subjects. J Transl Med. 2010 Apr 08; 8:34. Mikirova NA, Jackson JA, Hunninghake R, Kenyon J, Chan KW, Swindlehurst CA, Minev B, Patel AN, Murphy MP, Smith L, Ramos F, Ichim TE, Riordan NH. PMID: 20377846; PMCID: PMC2862021.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCellsCTClinical Trials
    34. Autologous stromal vascular fraction cells: a tool for facilitating tolerance in rheumatic disease. Cell Immunol. 2010; 264(1):7-17. Ichim TE, Harman RJ, Min WP, Minev B, Solano F, Rodriguez JP, Alexandrescu DT, De Necochea-Campion R, Hu X, Marleau AM, Riordan NH. PMID: 20537320.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    35. Delivery of a peptide via poly(D,L-lactic-co-glycolic) acid nanoparticles enhances its dendritic cell-stimulatory capacity. Nanomedicine. 2010 Oct; 6(5):651-61. Clawson C, Huang CT, Futalan D, Seible DM, Saenz R, Larsson M, Ma W, Minev B, Zhang F, Ozkan M, Ozkan C, Esener S, Messmer D. PMID: 20348031; PMCID: PMC2947606.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansAnimalsCells
    36. Induction characterization and targeting of human hematopoietic cancer stem cells. J Stem Cells. 2010; 5(1):1-7. Zhang M, Dias P, Minev B, Koka PS. PMID: 20861923.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    37. Circulating endothelial progenitor cells: a new approach to anti-aging medicine? J Transl Med. 2009 Dec 15; 7:106. Mikirova NA, Jackson JA, Hunninghake R, Kenyon J, Chan KW, Swindlehurst CA, Minev B, Patel AN, Murphy MP, Smith L, Alexandrescu DT, Ichim TE, Riordan NH. PMID: 20003528; PMCID: PMC2804590.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansAnimalsCells
    38. Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis. J Transl Med. 2009 Apr 24; 7:29. Riordan NH, Ichim TE, Min WP, Wang H, Solano F, Lara F, Alfaro M, Rodriguez JP, Harman RJ, Patel AN, Murphy MP, Lee RR, Minev B. PMID: 19393041; PMCID: PMC2679713.
      View in: PubMed   Mentions: 108     Fields:    Translation:HumansAnimalsCells
    39. Human embryonic stem cells hemangioblast express HLA-antigens. J Transl Med. 2009 Apr 22; 7:27. Basak GW, Yasukawa S, Alfaro A, Halligan S, Srivastava AS, Min WP, Minev B, Carrier E. PMID: 19386101; PMCID: PMC2680830.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    40. Feasibility investigation of allogeneic endometrial regenerative cells. J Transl Med. 2009 Feb 20; 7:15. Zhong Z, Patel AN, Ichim TE, Riordan NH, Wang H, Min WP, Woods EJ, Reid M, Mansilla E, Marin GH, Drago H, Murphy MP, Minev B. PMID: 19232091; PMCID: PMC2649897.
      View in: PubMed   Mentions: 68     Fields:    Translation:HumansCells
    41. Inhibition of intracranial glioma growth by endometrial regenerative cells. Cell Cycle. 2009 Feb 15; 8(4):606-10. Han X, Meng X, Yin Z, Rogers A, Zhong J, Rillema P, Jackson JA, Ichim TE, Minev B, Carrier E, Patel AN, Murphy MP, Min WP, Riordan NH. PMID: 19197154.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansAnimals
    42. Exosomes as a tumor immune escape mechanism: possible therapeutic implications. J Transl Med. 2008 Jul 22; 6:37. Ichim TE, Zhong Z, Kaushal S, Zheng X, Ren X, Hao X, Joyce JA, Hanley HH, Riordan NH, Koropatnick J, Bogin V, Minev BR, Min WP, Tullis RH. PMID: 18644158; PMCID: PMC2504474.
      View in: PubMed   Mentions: 52     Fields:    Translation:HumansCells
    43. Antigenic profiling of glioma cells to generate allogeneic vaccines or dendritic cell-based therapeutics. Clin Cancer Res. 2007 Jan 15; 13(2 Pt 1):566-575. Zhang JG, Eguchi J, Kruse CA, Gomez GG, Fakhrai H, Schroter S, Ma W, Hoa N, Minev B, Delgado C, Wepsic HT, Okada H, Jadus MR. PMID: 17255279; PMCID: PMC4030524.
      View in: PubMed   Mentions: 89     Fields:    Translation:HumansCells
    44. Dendritic cell activating peptides induce distinct cytokine profiles. Int Immunol. 2006 Nov; 18(11):1563-73. Telusma G, Datta S, Mihajlov I, Ma W, Li J, Yang H, Newman W, Messmer BT, Minev B, Schmidt-Wolf IG, Tracey KJ, Chiorazzi N, Messmer D. PMID: 16966494.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansAnimalsCells
    45. Preparation of murine B7.1-glycosylphosphatidylinositol and transmembrane-anchored staphylococcal enterotoxin. A dual-anchored tumor cell vaccine and its antitumor effect. Cancer. 2005 Apr 01; 103(7):1519-28. Yi P, Yu H, Ma W, Wang Q, Minev BR. PMID: 15739200.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    46. Chimerism and tolerance post-in utero transplantation with embryonic stem cells. Transplantation. 2004 Nov 15; 78(9):1274-82. Moustafa ME, Srivastava AS, Nedelcu E, Donahue J, Gueorguieva I, Shenouda SS, Minev B, Carrier E. PMID: 15548963.
      View in: PubMed   Mentions: 4     Fields:    Translation:Animals
    47. Technology evaluation: HSPPC-96, antigenics. Curr Opin Mol Ther. 2003 Dec; 5(6):680-7. Minev BR. PMID: 14755896.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    48. Immunotherapy and prostate cancer. Cancer Treat Rev. 2003 Jun; 29(3):199-209. Kaminski JM, Summers JB, Ward MB, Huber MR, Minev B. PMID: 12787714.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    49. Vaccines for immunotherapy of breast cancer and prostate cancer: new developments and comparative aspects. In Vivo. 2002 Nov-Dec; 16(6):405-15. Minev BR, Guo F, Gueorguieva I, Kaiser HE. PMID: 12494883.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    50. Melanoma vaccines. Semin Oncol. 2002 Oct; 29(5):479-93. Minev BR. PMID: 12407513.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    51. Conjugates of aberrant gangliosides in antiglioma vaccine: toxicological assay. Bull Exp Biol Med. 2002 Oct; 134(4):363-5. Lombardi V, Shnaar R, Minev B, Misasi R, Gitstsi Kh, Sorice M, Troncone A. PMID: 12533760.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    52. A novel melanoma gene (MG50) encoding the interleukin 1 receptor antagonist and six epitopes recognized by human cytolytic T lymphocytes. Cancer Res. 2000 Nov 15; 60(22):6448-56. Mitchell MS, Kan-Mitchell J, Minev B, Edman C, Deans RJ. PMID: 11103812.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    53. Cancer vaccines: an update. In Vivo. 2000 Sep-Oct; 14(5):571-85. Hipp JD, Hipp JA, Lyday BW, Minev BR. PMID: 11125541.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    54. Synthetic insertion signal sequences enhance MHC class I presentation of a peptide from the melanoma antigen MART-1. Eur J Immunol. 2000 Aug; 30(8):2115-24. Minev BR, Chavez FL, Dudouet BM, Mitchell MS. PMID: 10940901.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    55. Cytotoxic T cell immunity against telomerase reverse transcriptase in humans. Proc Natl Acad Sci U S A. 2000 Apr 25; 97(9):4796-801. Minev B, Hipp J, Firat H, Schmidt JD, Langlade-Demoyen P, Zanetti M. PMID: 10759561; PMCID: PMC18312.
      View in: PubMed   Mentions: 69     Fields:    Translation:HumansAnimalsCells
    56. Cancer vaccines: novel approaches and new promise. Pharmacol Ther. 1999 Feb; 81(2):121-39. Minev BR, Chavez FL, Mitchell MS. PMID: 10190583.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    57. New trends in the development of cancer vaccines. In Vivo. 1998 Nov-Dec; 12(6):629-38. Minev BR, Chavez FL, Mitchell MS. PMID: 9891226.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    58. Insertion signal sequence fused to minimal peptides elicits specific CD8+ T-cell responses and prolongs survival of thymoma-bearing mice. Cancer Res. 1994 Aug 01; 54(15):4155-61. Minev BR, McFarland BJ, Spiess PJ, Rosenberg SA, Restifo NP. PMID: 7518351; PMCID: PMC2254935.
      View in: PubMed   Mentions: 30     Fields:    Translation:AnimalsCells
    59. Enhancing the recognition of tumour associated antigens. Folia Biol (Praha). 1994; 40(1-2):74-88. Restifo NP, Minev BR, Taggarse AS, McFarland BJ, Wang M, Irvine KR. PMID: 7958066; PMCID: PMC2763578.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    Boris's Networks
    Concepts (271)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (12)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSD Profiles is managed by the UC San Diego Altman Clinical and Translational Research Institute (ACTRI).
    This site is running Profiles RNS version UCSF-v3.1.0-21-g9d46e6c4 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California